Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas

NANot yet recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

October 30, 2028

Study Completion Date

October 30, 2028

Conditions
PAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
Interventions
OTHER

blood sampling at inclusion, 6 months, 1 year and 2 years. Tumor and intracystic fluid samples are taken only if a biopsy is planned following MRI results.

If the patient agrees to take part in the study, he or she will have a blood sample taken from 8 x 4 ml EDTA tubes at the time of inclusion in the trial.Then, at 6 months (+/- 1 month), 1 year and 2 years, the patient will have the same blood sample as at inclusion.If a biopsy is performed as part of routine care, a tumor sample will be taken and sent to the IPC pathology department for FFPE block. If a biopsy is performed and the patient consents, a cystic fluid sample will be taken.

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT06000553 - Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas | Biotech Hunter | Biotech Hunter